Reliability Of Hand-Held Dynamometry For Measuring Force Production In People With Parkinson’S Disease,
2023
University of Canberra
Reliability Of Hand-Held Dynamometry For Measuring Force Production In People With Parkinson’S Disease, Matthew Boom, Elisabeth Preston, Renee Salmon, Louise Ada, Allyson Flynn
Internet Journal of Allied Health Sciences and Practice
Purpose: People with Parkinson’s disease (PD) have impaired force production, which is associated with decreased mobility and falls risk. Reliable measurement of force production is important. Design: A repeated-measures, intra- and inter-rater reliability study was undertaken. Participants: 24 people with mild PD were measured by one or two raters. Outcome measures: Isometric force of the major upper and lower limb muscle groups was measured using hand-held dynamometry. Results: Fourteen participants were measured by the same rater on two occasions to determine intra-rater reliability. Ten participants were measured on two occasions by two different raters to determine …
Infiltrating Cd8+ T Cells Exacerbate Alzheimer’S Disease Pathology In A 3d Human Neuroimmune Axis Model,
2023
Virginia Commonwealth University
Infiltrating Cd8+ T Cells Exacerbate Alzheimer’S Disease Pathology In A 3d Human Neuroimmune Axis Model, Jefin Jose, Devam Purohit
VCU's Medical Journal Club: The Work of Future Health Professionals
In this study, Jorfi et al. employed a neuroimmune axis model containing neurons, astrocytes, and microglia to examine the role of immune cells in Alzheimer's disease. Jorfi et al. found that T cells selectively infiltrated the BRAIN compartment of the neuroimmune axis model as compared to B cells and monocytes. Jorfi et al. further found that CD8+ T cells demonstrated heightened cytotoxicity in the Alzheimer's disease brain, illuminating the role of immune cells in neurodegeneration. Upon further examination, the CXCR3-CXCL10 signaling pathway was found to have an important role in inflammation.
A Genome-Wide In Vivo Crispr Screen Identifies Essential Regulators Of T Cell Migration To The Cns In A Multiple Sclerosis Model,
2023
Virginia Commonwealth University
A Genome-Wide In Vivo Crispr Screen Identifies Essential Regulators Of T Cell Migration To The Cns In A Multiple Sclerosis Model, Jefin Jose
VCU's Medical Journal Club: The Work of Future Health Professionals
Kendirli et al. (2023) used a CRISPR screen to determine the proteins involved in T cell migration into the CNS in multiple sclerosis. Overall, eighteen facilitators and five brakes to T cell infiltration into the CNS were identified. Kendirli et al. specifically identified ITGA4, FERMT3, and HSP90B1 to make up the adhesion module, CXCR3, GNAI2, and TBX21 to make up the chemotaxis module, and GRK2 and S1PR2 to make up the egress module. This study demonstrated the ability of a CRISPR screen to identify elements in a disease process and thus identify targets for future multiple sclerosis therapies.
Benefits Of Medical Thc For Neurological Disorders In The U.S.,
2023
Marshall University
Benefits Of Medical Thc For Neurological Disorders In The U.S., Andrew Lester, Alexandria Gartin
Theses, Dissertations and Capstones
Introduction: The introduction of THC into the medical field has allowed medical professionals to offer a new treatment option to aid in their patients treatment plan by decreasing their symptoms of side effects of other medications used for their conditions.
Methodology: This study utilized a literature review. Five databases were used to collect 116 total sources. These sources were reviewed and reduced to 33 sources that were used in the written research. Of these, 16 sources were used in the results section.
Purpose of the Study: The purpose of this research was to analyze the prescription use of …
Cauda Equina Neuroendocrine Tumor (Paraganglioma),
2023
HCA Healthcare
Cauda Equina Neuroendocrine Tumor (Paraganglioma), Cameron Summers-Powell, Tricia O'Brien, Susana Ferra
East Florida Division GME Research Day 2023
No abstract available.
Guillain-Barré Syndrome: Recognizing Variations In Clinical Presentations,
2023
HCA Healthcare
Guillain-Barré Syndrome: Recognizing Variations In Clinical Presentations, Andrew Wang, Komal Luthra
Gulf Coast Division GME Research Day 2023
No abstract provided.
Multiple Sclerosis In A 32-Year-Old Female With History Of Prolactinoma,
2023
HCA Healthcare
Multiple Sclerosis In A 32-Year-Old Female With History Of Prolactinoma, Aleeza Ali, Jesse Simon, Adekunle Bamgboye
East Florida Division GME Research Day 2023
Among disorders affecting the central nervous system (CNS), excluding trauma, multiple sclerosis (MS) is the most common cause of permanent disability in young adults. This condition is characterized by IgG autoantibody-mediated destruction of oligodendrocytes in the brain and spinal cord. Although the origin of MS is not fully understood, some suggest that prolactin may be involved in the development of the disease process evidenced by the fact that it predominately affects women of childbearing age, and the diverse role of prolactin (PRL) as a peptide hormone, cytokine, and immune modulator. Here we review the case of a 32-year-old female with …
Extra-Axial Desmoplastic/Nodular Medulloblastoma, Shh-Activated In Adult: A Case Report,
2023
HCA Healthcare
Extra-Axial Desmoplastic/Nodular Medulloblastoma, Shh-Activated In Adult: A Case Report, Gul Wymer, Fatemeh Mousavi, Jennifer Barker
East Florida Division GME Research Day 2023
Introduction: Medulloblastoma (MB) is an embryonal central nervous system (CNS) tumor located in the posterior cranial fossa. Medulloblastoma is one of the most common malignant pediatric brain tumors, accounts for 25% of all pediatric intracranial tumors, but rare in adults; and constitute 0.4%-1% of adult primary brain tumors. The incidence of medulloblastomas in adults is approximately 0.5 per million per year and decreases with age with male predominance. Medulloblastomas classically appear as well-defined masses in the cerebellum that enhance both computed tomography (CT) of the head and brain magnetic resonance imaging (MRI) with gadolinium contrast. The clinical symptoms and signs …
Left Atrial Enlargement In Primary Cryptogenic Strokes Without Atrial Fibrillation,
2023
HCA Healthcare
Left Atrial Enlargement In Primary Cryptogenic Strokes Without Atrial Fibrillation, Hytham Rashid, Jonathan Brown, Negar Niknam, Tusharkumar Pansuriya, Sivatej Sarva, Syed Danyal Raza
Gulf Coast Division GME Research Day 2023
No abstract provided.
Tea, Toast, And Strokes,
2023
HCA Healthcare
Tea, Toast, And Strokes, Mark Azmy, Jennifer Broyles, Sean Quinonez, Admir Seferovic
West Florida Division GME Research Day 2023
No abstract provided.
Regional Fa Values And Loss Of Consciousness In Mild Traumatic Brain Injury,
2023
HCA Healthcare
Regional Fa Values And Loss Of Consciousness In Mild Traumatic Brain Injury, Alexander Asturias, Thomas Knoblauch, Alan Rodriguez, Cheryl Vanier, Caroline Le Tohic, Brandon Barrett, Michael Eisenberg, Rachelle Gibbert, Lennon Zimmerman, Shaunaq Parikh, Anh Nguyen, Sherwin Azad, Leo Germin, Enrico Fazzini, Travis Snyder
Far West Division GME Research Day 2023
No abstract provided.
A Case Of Thrombolytic Associated Ich In The Setting Of Infective Endocarditis,
2023
HCA Healthcare
A Case Of Thrombolytic Associated Ich In The Setting Of Infective Endocarditis, Priscilla Yan, Lama Al-Khoury
Far West Division GME Research Day 2023
No abstract provided.
Challenges Of Cerebral Hyperperfusion Syndrome: A Clinical Case Report,
2023
HCA Healthcare
Challenges Of Cerebral Hyperperfusion Syndrome: A Clinical Case Report, Ruth Williams, Ranga Rathakrishnan
East Florida Division GME Research Day 2023
Introduction: Cerebral Hyperperfusion syndrome (CHS) is a clinical syndrome of hypertension, headache, neurological deficits, with or without seizures, following a revascularization procedure. It is characterized by an excessive and sudden increase in cerebral blood flow. The mechanism is largely not understood but theories involve impaired cerebrovascular autoregulation (thought to be mitigated by collateral circulation), free radical damage, and baroreceptor reflex damage, possible from the procedure itself1 . Common presentations include severe ipsilateral headache to the side of the lesion with typical onset within 12 hours to 6 days, but can occur up to one month, after carotid revascularization processes2 . …
Unique Presentation Of Cerebritis: A Case Report,
2023
HCA Healthcare
Unique Presentation Of Cerebritis: A Case Report, Wajahat Dawood, Kevin Jiang, Bryan Kharbanda
Gulf Coast Division GME Research Day 2023
No abstract provided.
A Rare Case Of Pres In A Patient On Bevacizumab-Awwb Chemotherapy,
2023
HCA Healthcare
A Rare Case Of Pres In A Patient On Bevacizumab-Awwb Chemotherapy, Alexander Rhodes, John Punla, Aswin Srinivasan, An Dao, Syed Raza
Gulf Coast Division GME Research Day 2023
No abstract provided.
The Treatment Of Rem Sleep Disorder Using Neuromodulation: A Literature Review,
2023
HCA Healthcare
The Treatment Of Rem Sleep Disorder Using Neuromodulation: A Literature Review, Aaron Marbin, Shane Ragland, Orestes Hadjistamoulou, Clara Alvarez Villalba, Samuel Neuhut
East Florida Division GME Research Day 2023
No abstract available.
The Treatment Of Depression In Alzheimer's Disease Using Neuromodulation: A Literature Review,
2023
HCA Healthcare
The Treatment Of Depression In Alzheimer's Disease Using Neuromodulation: A Literature Review, Aaron Marbn, Shane Ragland, Thalia Adrian, Clara Alvarez Villalba, Samuel Neuhut
East Florida Division GME Research Day 2023
Please see supplemental content for full abstract with references.
INTRODUCTION: An estimated 44 million individuals live with Alzheimer's Dementia globally, a number expected to triple by 2050.1 Depression is a commonly observed comorbidity in individuals with Alzheimer's disease. Traditional antidepressant medications often pose challenges due to their side effects and limited efficacy in this population. As a result, alternative therapeutic approaches are being explored, with Transcranial Magnetic Stimulation (TMS) emerging as a promising intervention for treating depression in Alzheimer's patients. TMS is a non-invasive brain stimulation technique that utilizes magnetic fields to modulate neural activity in targeted brain regions …
Moyamoya Disease Presenting As An Intracranial Hemorrhage In A 69-Year-Old Male,
2023
HCA Healthcare
Moyamoya Disease Presenting As An Intracranial Hemorrhage In A 69-Year-Old Male, Jorge Rodriguez, Brittany Chandani, David G. Gelikman, Ankur Garg, Olga Karasik
North Florida Division GME Research Day 2023
No abstract provided.
Posterior Reversible Encephalopathy Syndrome: A Case Of Elevated Blood Pressure And New Seizure Onset Post Nephrectomy,
2023
HCA Healthcare
Posterior Reversible Encephalopathy Syndrome: A Case Of Elevated Blood Pressure And New Seizure Onset Post Nephrectomy, Jessica Bautista, Kyle Adkins, Lisa Gieseke
Continental, MidAmerica, & Mountain Divisions GME Research Day 2023
No abstract provided.
Wernicke Encephalopathy: Interplay Between Magnesium And Thiamine,
2023
HCA Healthcare
Wernicke Encephalopathy: Interplay Between Magnesium And Thiamine, Richard Allen Gorman Ii, Mark Stine, Rafael Vaello, Patrick J. Stocker
West Florida Division GME Research Day 2023
No abstract provided.
